Amlodipine and endothelial nitric oxide synthase activity

Cardiovascular Research

Volumn 59, Issue 4, 2003, Pages 807-809

  Tabrizchi, Reza ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 (2 AMINOETHOXY)ETHOXY]METHYL] 4 (2,3 DICHLOROPHENYL) 1,4 DIHYDRO 6 METHYL 3,5 PYRIDINEDICARBOXYLIC ACID 3 ETHYL 5 METHYL ESTER; AMLODIPINE; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MIBEFRADIL; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; NIMODIPINE; NISOLDIPINE; NITRENDIPINE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE C; VOLTAGE GATED CALCIUM CHANNEL;

CALCIUM TRANSPORT; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG MECHANISM; EDITORIAL; ENZYME PHOSPHORYLATION; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HUMAN; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; REVASCULARIZATION; SMOOTH MUSCLE FIBER; UNSTABLE ANGINA PECTORIS; VASODILATATION;

AMLODIPINE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR SYSTEM; ENZYME ACTIVATION; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; VASODILATION;

EID: 1642416041     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00525-X     Document Type: Editorial

References (17)

1. 495. Cardiovasc Res. 59:2003;844-853.
2. Epstein M. Calcium antagonists in clinical medicine. 1992;Hanley & Belfus, Philadelphia, PA.
3. Packer M., O'Connor C.M., Ghali J.K., et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure: Prospective Randomized Amlodipine Survival Evaluation Study Group. New Engl J Med. 335:1996;1107-1114.
4. Pitt B., Byington R.P., Furberg C.D., et al. Effect of amlodipine on the progression of atherosclerosis and occurrence of clinical events. PREVENT Investigators. Circulation. 102:2000;1503-1510.
5. Vilaine J.P., Biondi M.L., Villeneuve N., et al. The calcium channel antagonist S 11568 causes endothelium-dependent relaxation in canine arteries. Eur J Pharmacol. 197:1991;41-48.
6. 2+ antagonist RO 40-5967 on endothelium-dependent responses of isolated arteries. J Cardiovasc Pharmacol. 23:1994;869-876.
7. Dhein S., Zhao Y., Simsek S., et al. Actions of 1,4-dihydropyridines in isolated mesenteric vascular beds. J Cardiovasc Pharmacol. 26:1995;784-791.
8. Salameh A., Schomecker G., Breitkopf K., et al. The effect of the calcium-antagonist nitrendipine on intracellular calcium concentration in endothelial cells. Br J Pharmacol. 118:1996;1899-1904.
9. Zhang X., Hintze T.H. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation. 97:1998;576-580.
10. Kitakazi M., Node J., Minamino T., et al. A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via an NO-dependent mechanisms in dogs. J Am Coll Cardiol. 33:1999;242-249.
11. Loke K.E., Messina E.J., Shesely E.G., et al. Potential role of eNOS in the therapeutic control of myocardial oxygen consumption by ACE inhibitors and amlodipine. Cardiovasc Res. 49:2001;86-93.
12. Zhang X.-P., Loke K.E., Mital S., et al. Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the R+ enantiomer of amlodipine. J Cardiovasc Pharmacol. 39:2002;208-214.
13. Fleming I., Busse R. Signal transduction of eNOS activation. Cardiovasc Res. 43:1999;532-541.
14. Aoyagi M., Arvai A.S., Tainer J.A., et al. Structural basis for endothelial nitric oxide synthase binding to calmodulin. EMBO J. 22:2003;766-775.
15. 2-kinin receptor knockout mice. Hypertension. 34:1999;563-567.
16. ω nitro-L-arginine methyl ester on relaxant responses to calcium channel antagonists in isolated aortic rings from Dahl normotensive and hypertensive rats. J Cardiovasc Pharmacol. 39:2002;354-362.
17. 1-adrenoceptor-mediated contractions in aortic rings from Dahl normotensive and hypertensive rats. Cardiovasc Res. 48:2000;393-401.